tumorsMalignant tumoursMalignant tumours2224-50572587-6813Rosoncoweb10.18027/2224-5057-2012-2-14-20tumors-8Research ArticleОБЗОРЫ И АНАЛИТИКАREVIEWS AND ANALYSISРОЛЬ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ ЭПИТЕЛИАЛЬНОГО РАКА ЯИЧНИКОВNarendraH.

Department of surgical oncology, Kasturba Medical College, Manipal University, Manipal, India 576104

drnarendrah@yahoo.co.inDepartment of surgical oncology, Kasturba Medical College, Manipal UniversityIndia201219052015121420Copyright © Narendra H., 20152015Narendra H.Narendra H.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.malignanttumors.org/jour/article/view/8

Хирургический подход используется у больных эпителиальным раком яичников с целью диагностики и стадирования, радикального и паллиативного лечения. Эта статья посвящена роли хирургии в профилактике, диагностике, стадировании и лечении ранних и распространенных форм заболевания. В статье также кратко освящено паллиативное хирургическое лечение.

эпителиальный рак яичниковхирургическое лечениеReferencesChaudhry K. Epidemiology of Cancer of Ovary: Changing Trends. Indian journal of medical & paediatric oncology. 30:suppl 1.2009.8.Chaudhry K. Epidemiology of Cancer of Ovary: Changing Trends. Indian journal of medical & paediatric oncology. 30:suppl 1.2009.8.Permuth-Wey J., Sellers T.A.. Epidemiology of ovarian cancer. Methods in Molecular Biology, 2009;472:413–437.Permuth-Wey J., Sellers T.A.. Epidemiology of ovarian cancer. Methods in Molecular Biology, 2009;472:413–437.Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109:221-227.Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109:221-227.Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009;10:327–40.Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009;10:327–40.Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA. 2006 ;296:185-92.Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA. 2006 ;296:185-92.Aletti GD, Gallenberg MM,Cliby WA, Jatoi A, Hartmann LC. Current Management Strategies for Ovarian Cancer. Mayo Clin Proc. 2007;82:751-770.Aletti GD, Gallenberg MM,Cliby WA, Jatoi A, Hartmann LC. Current Management Strategies for Ovarian Cancer. Mayo Clin Proc. 2007;82:751-770.Kauff ND, Barakat RR. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2. J Clin Oncol. 2007 ;25:2921-7.Kauff ND, Barakat RR. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2. J Clin Oncol. 2007 ;25:2921-7.Young RC, Decker DG, Wharton JT, et al. Staging laparotomy in early ovarian cancer. JAMA. 1983;250:3072-6.Young RC, Decker DG, Wharton JT, et al. Staging laparotomy in early ovarian cancer. JAMA. 1983;250:3072-6.Meier WJ. Lymphadenectomy in stage I ovarian cancer. Proc Am Soc Clin Oncol 2000;19:1541.Meier WJ. Lymphadenectomy in stage I ovarian cancer. Proc Am Soc Clin Oncol 2000;19:1541.Benedetti-Panici P, Greggi S, Maneschi F, et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 1993;51:150-4.Benedetti-Panici P, Greggi S, Maneschi F, et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 1993;51:150-4.Petru E, Lahousen M, Tamussino K, et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 1994;170:656-62.Petru E, Lahousen M, Tamussino K, et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 1994;170:656-62.Baiocchi G, Raspagliesi F, Grosso G, et al. Early ovarian cancer: Is there a role for systematic pelvis and paraortic lymphadenectomy? Int J Gynecol Cancer 1998;8:103-108.Baiocchi G, Raspagliesi F, Grosso G, et al. Early ovarian cancer: Is there a role for systematic pelvis and paraortic lymphadenectomy? Int J Gynecol Cancer 1998;8:103-108.Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer. J Clin Oncol. 2007;25:1-16.Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer. J Clin Oncol. 2007;25:1-16.Chan JK, Urban R, Hu JM, et al. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer. 2007;96:1817-22.Chan JK, Urban R, Hu JM, et al. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer. 2007;96:1817-22.Maggioni A, Panici PB, Dell›Anna T, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95:699-704.Maggioni A, Panici PB, Dell›Anna T, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95:699-704.Vergote I. Role of surgery in ovarian cancer: an update. Acta Chir Beig. 2004;104:246-56.Vergote I. Role of surgery in ovarian cancer: an update. Acta Chir Beig. 2004;104:246-56.Earle CC, Schrag D, Neville BA, et al. Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients. J Natl Cancer Inst 2006;98:172 – 80.Earle CC, Schrag D, Neville BA, et al. Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients. J Natl Cancer Inst 2006;98:172 – 80.Engelen MJA., Kos HE, Willemse PHB, et al. Surgery by Consultant Gynecologic Oncologists Improves Survival in Patients with Ovarian Carcinoma. Cancer 2006;106:589–98.Engelen MJA., Kos HE, Willemse PHB, et al. Surgery by Consultant Gynecologic Oncologists Improves Survival in Patients with Ovarian Carcinoma. Cancer 2006;106:589–98.Martinek IE, Kehoe S. When Should Surgical Cytoreduction in Advanced Ovarian Cancer Take Place? J Oncol. 2010:85;20-28.Martinek IE, Kehoe S. When Should Surgical Cytoreduction in Advanced Ovarian Cancer Take Place? J Oncol. 2010:85;20-28.Van Gorp T, Amant F, Neven P, Berteloot P, Leunen K, Vergote I. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer. Minerva Ginecol. 2006;58:393-403.Van Gorp T, Amant F, Neven P, Berteloot P, Leunen K, Vergote I. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer. Minerva Ginecol. 2006;58:393-403.Horng HC, Yuan CC, Lai CR, Wang PH. Presumed Stage IA primary epithelial ovarian carcinoma: the role of complete staging surgery. Eur J Gynaecol Oncol. 2007;28:43-4.Horng HC, Yuan CC, Lai CR, Wang PH. Presumed Stage IA primary epithelial ovarian carcinoma: the role of complete staging surgery. Eur J Gynaecol Oncol. 2007;28:43-4.Bae J, Lim MC, Choi JH, et al. Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. J Gynecol On col.2009;20:101-106.Bae J, Lim MC, Choi JH, et al. Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. J Gynecol On col.2009;20:101-106.Park JY, Kim DY, Suh DS, et al. Outcomes of fertilitysparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol. 2008;110:345-53.Park JY, Kim DY, Suh DS, et al. Outcomes of fertilitysparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol. 2008;110:345-53.Schlaerth AC, Chi DS, Poynor EA, Barakat RR, Brown CL. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Int J Gynecol Cancer. 2009;19:1199-204.Schlaerth AC, Chi DS, Poynor EA, Barakat RR, Brown CL. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Int J Gynecol Cancer. 2009;19:1199-204.Kesic V. Fertility after the treatment of gynecologic tumors. Recent Results Cancer Res. 2008;178:79-95.Kesic V. Fertility after the treatment of gynecologic tumors. Recent Results Cancer Res. 2008;178:79-95.Kwon YS, Hahn SH, Kim TJ, et al. Fertility preservation in patients with early epithelial ovarian cancer. J Gynecol Oncol. 2009; 20:44-47.Kwon YS, Hahn SH, Kim TJ, et al. Fertility preservation in patients with early epithelial ovarian cancer. J Gynecol Oncol. 2009; 20:44-47.Canis M, Jardon K, Niro J, et al. [Endoscopic management of gynecological malignancies: an update. 2007. Bull Acad Natl Med. 2007;191:1357-65.Canis M, Jardon K, Niro J, et al. [Endoscopic management of gynecological malignancies: an update. 2007. Bull Acad Natl Med. 2007;191:1357-65.Jung US, Lee JH, Kyung MS, Choi JS. Feasibility and efficacy of laparoscopic management of ovarian cancer. J. Obstet. Gynaecol. Res 2009;35:113–118.Jung US, Lee JH, Kyung MS, Choi JS. Feasibility and efficacy of laparoscopic management of ovarian cancer. J. Obstet. Gynaecol. Res 2009;35:113–118.Park JY, Bae J, Lim MC, et al. Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety. Int J Gynecol Cancer. 2008;18:1202-9.Park JY, Bae J, Lim MC, et al. Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety. Int J Gynecol Cancer. 2008;18:1202-9.Park JY, Kim DY, Suh DS, et al. Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Ann Surg Oncol. 2008;15:2012-9.Park JY, Kim DY, Suh DS, et al. Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Ann Surg Oncol. 2008;15:2012-9.Liu CS, Nagarsheth NP, Nezhat FR. Laparoscopy and ovarian cancer: a paradigm change in the management of ovarian cancer? J Minim Invasive Gynecol. 2009; 16:250-62.Liu CS, Nagarsheth NP, Nezhat FR. Laparoscopy and ovarian cancer: a paradigm change in the management of ovarian cancer? J Minim Invasive Gynecol. 2009; 16:250-62.

The authors declare that there are no conflicts of interest present.